Evidence map›Paper›PMID 31565083›Full record

ArticleCellular and molecular bioengineering2019

Cell-Cell Mechanical Communication in Cancer.

Samantha C Schwager, Paul V Taufalele, Cynthia A Reinhart-King

Abstract read
In one paragraph

Article in Cellular and molecular bioengineering, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Cell-cell communication: new insights and clinical implications.Signal transduction and targeted therapy · 2024
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Samantha C Schwager *Department of Biomedical Engineering, Vanderbilt University, PMB 351631, Nashville, TN 37235 USA.
Paul V Taufalele *Department of Biomedical Engineering, Vanderbilt University, PMB 351631, Nashville, TN 37235 USA.
Cynthia A Reinhart-KingDepartment of Biomedical Engineering, Vanderbilt University, PMB 351631, Nashville, TN 37235 USA.ORCID 0000-0001-6959-3914

Funding

Mechanical Regulation of Tumor AngiogenesisR01HL127499 · NHLBI · VANDERBILT UNIVERSITY · PI REINHART-KING, CYNTHIA A. · 2015 to 2019
$2.4M
NHLBI NIH HHS R01 HL127499
6 · The paper itself

Abstract

Communication between cancer cells enables cancer progression and metastasis. While cell-cell communication in cancer has primarily been examined through chemical mechanisms, recent evidence suggests that mechanical communication through cell-cell junctions and cell-ECM linkages is also an important mediator of cancer progression. Cancer and stromal cells remodel the ECM through a variety of mechanisms, including matrix degradation, cross-linking, deposition, and physical remodeling. Cancer cells sense these mechanical environmental changes through cell-matrix adhesion complexes and subsequently alter their tension between both neighboring cells and the surrounding matrix, thereby altering the force landscape within the microenvironment. This communication not only allows cancer cells to communicate with each other, but allows stromal cells to communicate with cancer cells through matrix remodeling. Here, we review the mechanisms of intercellular force transmission, the subsequent matrix remodeling, and the implications of this mechanical communication on cancer progression.

Indexed as

cell mechanicsextracellular matrixintercellular forcemechanosensingMechanotransduction

Identifiers

PMID31565083
PMCPMC6764766

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.